Skip to content

The effect of aroma with rose damascena essence on nausea and vomiting of chemotherapy

Effect of aromatherapy with rosa Damascena essence on nausea and vomiting in patients with breast cancer undergoing chemotherapy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211117053090N1
Enrollment
76
Registered
2022-01-22
Start date
2022-01-10
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-induced nausea and vomiting in breast cancer.

Interventions

Intervention 1: Intervention group: 38 women with breast cancer participated in the study according to the inclusion criteria. Each participant was given a package containing 20ml dropper bottle (cont

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Definitive diagnosis of breast cancer by oncologist and pathologist Chemotherapy with drugs that cause moderate to severe nausea Having a nausea severity above 3 cm using the 10 cm VAS scale Healthy sense of smell Being over 18 years old

Exclusion criteria

Exclusion criteria: Having migraines and chronic headaches Having a history of asthma and allergy to rosa damacena History of drug and alcohol addiction Having mental illness Having liver and kidney disease

Design outcomes

Primary

MeasureTime frame
Severity of Nausea. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention. Method of measurement: Visual Analogue Scale.;The frequency of vomiting. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention. Method of measurement: Rhodes Index.;The frequency of retching. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention. Method of measurement: Rhodes Index.

Secondary

MeasureTime frame
Amount of vomiting. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention . Method of measurement: Rhodes Index.;Distress score of vomiting. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention. Method of measurement: Rhodes Index.;Distress score of retching. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention. Method of measurement: Rhodes Index.;Total score of retching. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention. Method of measurement: Rhodes Index.;Total score of vomiting. Timepoint: 15 minutes before the start of chemotherapy (initially study) and 24 hours after the intervention. Method of measurement: Rhodes Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKiarash Tabaraei

Arak University of Medical Sciences

kiarashtabaraei@gmail.com+98 66 4332 3985

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026